uk122 Search Results


uk122  (MedChemExpress)
93
MedChemExpress uk122
A. Western blot showing that CAF23 conditioned media increases uPA protein in MDA-MB231 cells. B. qPCR of PLAU in MDA231 or DT28 cells treated for 3 days with non-targeting siRNAs (siNT) or PLAU siRNAs (siPLAU). PLAU was normalized to the 18S ribosomal RNA. Inset: Western blot of siNT or siPLAU MDA-MB231 cells. C. Endothelial binding assay of MDA-MB231, DT28 and SUM159 cells treated for 3 days with siNT or siPLAU. D. Time course of endothelial binding assay using MDA-MB231 cells treated with siNT or siPLAU showing % of cells bound for the indicated periods. E. Endothelial binding assay using MDA-MB231 cells pre-treated with vehicle or uPA inhibitor, <t>UK122,</t> for 24 hrs at increasing concentrations. * p ≥ 0.05, ** p ≥ 0.005, *** p ≥ 0.0005
Uk122, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/uk122/product/MedChemExpress
Average 93 stars, based on 1 article reviews
uk122 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
upa inhibitor ii  (Santa Cruz Biotechnology)
93
Santa Cruz Biotechnology upa inhibitor ii
A. Western blot showing that CAF23 conditioned media increases uPA protein in MDA-MB231 cells. B. qPCR of PLAU in MDA231 or DT28 cells treated for 3 days with non-targeting siRNAs (siNT) or PLAU siRNAs (siPLAU). PLAU was normalized to the 18S ribosomal RNA. Inset: Western blot of siNT or siPLAU MDA-MB231 cells. C. Endothelial binding assay of MDA-MB231, DT28 and SUM159 cells treated for 3 days with siNT or siPLAU. D. Time course of endothelial binding assay using MDA-MB231 cells treated with siNT or siPLAU showing % of cells bound for the indicated periods. E. Endothelial binding assay using MDA-MB231 cells pre-treated with vehicle or uPA inhibitor, <t>UK122,</t> for 24 hrs at increasing concentrations. * p ≥ 0.05, ** p ≥ 0.005, *** p ≥ 0.0005
Upa Inhibitor Ii, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/upa inhibitor ii/product/Santa Cruz Biotechnology
Average 93 stars, based on 1 article reviews
upa inhibitor ii - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
upa inhibitor ii, uk122  (Merck KGaA)
90
Merck KGaA upa inhibitor ii, uk122
A. Western blot showing that CAF23 conditioned media increases uPA protein in MDA-MB231 cells. B. qPCR of PLAU in MDA231 or DT28 cells treated for 3 days with non-targeting siRNAs (siNT) or PLAU siRNAs (siPLAU). PLAU was normalized to the 18S ribosomal RNA. Inset: Western blot of siNT or siPLAU MDA-MB231 cells. C. Endothelial binding assay of MDA-MB231, DT28 and SUM159 cells treated for 3 days with siNT or siPLAU. D. Time course of endothelial binding assay using MDA-MB231 cells treated with siNT or siPLAU showing % of cells bound for the indicated periods. E. Endothelial binding assay using MDA-MB231 cells pre-treated with vehicle or uPA inhibitor, <t>UK122,</t> for 24 hrs at increasing concentrations. * p ≥ 0.05, ** p ≥ 0.005, *** p ≥ 0.0005
Upa Inhibitor Ii, Uk122, supplied by Merck KGaA, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/upa inhibitor ii, uk122/product/Merck KGaA
Average 90 stars, based on 1 article reviews
upa inhibitor ii, uk122 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


A. Western blot showing that CAF23 conditioned media increases uPA protein in MDA-MB231 cells. B. qPCR of PLAU in MDA231 or DT28 cells treated for 3 days with non-targeting siRNAs (siNT) or PLAU siRNAs (siPLAU). PLAU was normalized to the 18S ribosomal RNA. Inset: Western blot of siNT or siPLAU MDA-MB231 cells. C. Endothelial binding assay of MDA-MB231, DT28 and SUM159 cells treated for 3 days with siNT or siPLAU. D. Time course of endothelial binding assay using MDA-MB231 cells treated with siNT or siPLAU showing % of cells bound for the indicated periods. E. Endothelial binding assay using MDA-MB231 cells pre-treated with vehicle or uPA inhibitor, UK122, for 24 hrs at increasing concentrations. * p ≥ 0.05, ** p ≥ 0.005, *** p ≥ 0.0005

Journal: bioRxiv

Article Title: Modeling the role of urokinase plasminogen activator, uPA, and circulating Cancer-Associated Fibroblasts (cCAFS) in breast cancer cell extravasation

doi: 10.1101/2025.06.11.659108

Figure Lengend Snippet: A. Western blot showing that CAF23 conditioned media increases uPA protein in MDA-MB231 cells. B. qPCR of PLAU in MDA231 or DT28 cells treated for 3 days with non-targeting siRNAs (siNT) or PLAU siRNAs (siPLAU). PLAU was normalized to the 18S ribosomal RNA. Inset: Western blot of siNT or siPLAU MDA-MB231 cells. C. Endothelial binding assay of MDA-MB231, DT28 and SUM159 cells treated for 3 days with siNT or siPLAU. D. Time course of endothelial binding assay using MDA-MB231 cells treated with siNT or siPLAU showing % of cells bound for the indicated periods. E. Endothelial binding assay using MDA-MB231 cells pre-treated with vehicle or uPA inhibitor, UK122, for 24 hrs at increasing concentrations. * p ≥ 0.05, ** p ≥ 0.005, *** p ≥ 0.0005

Article Snippet: The following chemicals were used in our studies: Bovine Hyaluronidase (StemCell Technologies), 4MU (Sigma Aldrich), UK122 (MedChemExpress), TGFβ1 (R and D Systems), Cell Tracker Deep Red (Invitrogen, C34565) or Cell Tracker Red (Invitrogen, C34552), FITC-lectin (Vector Laboratories).

Techniques: Western Blot, Binding Assay